arrow
I

Ismaila Théra

London School of Hygiene & Tropical Medicine
H指数:13
被引数:1,586

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E
2025-02-060
OAAI
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
2024-01-0117
OAAI
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1 randomised, controlled trial
2023-11-0117
PRE
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone
2022-10-0710
OAAI
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
2022-03-0150
OAAI
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine

儿童对季节性接种RTS,S/AS01E疟疾疫苗的抗环子孢子抗体反应

2021-12-117
OAAI
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
2021-09-09123
OA
The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Hounde, Burkina Faso, and Bougouni, Mali
2021-01-089
OAAI
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Hounde District, Burkina Faso and Bougouni District, Mali
2020-08-2122
OAAI
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

吡那啶-青蒿琥酯或双氢青蒿素-哌喹与目前的一线疗法用于重复治疗无并发症的疟疾: 一项随机,多中心,开放标签,纵向,对照,3b/4期试验

LANCET
IF88.5
2018-04-01102
OAAI
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
2017-05-01243
OAAI
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
2016-02-0158
OAAI